InspireMD (NSPR) EPS (Basic) Growth (5y) (2015 - 2025)
InspireMD (NSPR) EPS (Basic) Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.23 Bn | 196.63 Bn | 7.27 Bn |
| 2 | Stryker | 127.28 Bn | 123.80 Bn | 4.50 Bn |
| 3 | Medtronic | 119.00 Bn | 109.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.41 Bn | 73.88 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.77 Bn | 47.52 Bn | 1.35 Bn |
| 6 | Dexcom | 35.03 Bn | 33.09 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.80 Bn | 31.69 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.24 Bn | 22.92 Bn | 4.55 Bn |
| 9 | Steris | 23.20 Bn | 22.71 Bn | 684.20 Mn |
| 10 | InspireMD | 55.96 Mn | 1.75 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.03% |
| Sep 30, 2025 | 28.40% |
| Jun 30, 2025 | 38.63% |
| Mar 31, 2025 | 48.87% |
| Dec 31, 2024 | 40.30% |
| Sep 30, 2024 | 60.77% |
| Jun 30, 2024 | 60.49% |
| Mar 31, 2024 | 67.23% |
| Dec 31, 2023 | 60.60% |
| Sep 30, 2023 | 66.08% |
| Jun 30, 2023 | 70.61% |
| Mar 31, 2023 | 76.74% |
| Dec 31, 2022 | 85.90% |
| Sep 30, 2022 | 83.63% |
| Jun 30, 2022 | 83.90% |
| Mar 31, 2022 | 87.25% |
| Dec 31, 2021 | 89.44% |
| Sep 30, 2021 | 88.14% |
| Jun 30, 2021 | 91.78% |
| Mar 31, 2021 | 92.24% |